Steralyths are produced via electro-diaphragmalysis from distilled water with a mild
concentration of NaCl. This leads to a temporary (2 – 4 weeks) electro chemical activation.
Besides reactive oxygen species, the products contain different chlorine compounds and
have a high oxidation-reduction potential. Steralyths are not cytotoxic, biocompatible and
toxicologically safe.
Steralyth Solutions are wound irrigation solutions for cleansing and moistening of acute and
chronic wounds and wound dressings. Even in problematic cases, such as MRSA or
Pseudomonas populated wounds or skin, Steralyths contribute to wound cleansing and
decontamination. The solutions can be applied for irrigation of natural orifices and mucous
membranes. Beside the decontamination and cleaning there is a marked effect on the
wound healing process even of poorly circulated wounds. Therefore patients with burn
wounds, decubital defects, chronically contaminated wounds and ulcers, tropical ulcers as
well as complicated diabetic foot problems benefit from the application of Steralyths.
The production of Steralyths can be introduced in hospitals or pharmacies in developing
countries efficiently and are a low cost solution to make a product for effective management
of wounds, including complicated wounds available in settings with limited resources. The
method won a WHO innovation price and the Steralyths are registered for wound
management in Germany and Europe. The registration of the method to produce
disinfectant solutions is currently under way.
Case studies and the mode of production and application of Steralyths in an African hospital
setting will be presented.
Dr. med. K. Peter Schmitz
MD, Surgeon, Tropical Medicine, DHCMTC, Dipl. Ing.
IHPH - Institute for Hygiene and Public Health
WHO CC
University of Bonn
Sigmund-Freud-Str. 25
D - 53105 Bonn
Martina Janßen
MSc Human Biology, RN
Aquismed GmbH
Marburger Str. 86c
35043 Marburg / Germany